Trusopt 2% Eye Drops Solution
Out of date information, search anotherTRUSOPT® 2% EYE DROPS SOLUTION / DORZOLAMIDE 2% EYE DROPS SOLUTION
_(dorzolamide hydrochloride)_
3. HOW TO USE TRUSOPT
Always use Trusopt exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. The appropriate dosage and duration of treatment will be established by your doctor.
When this medicine is used alone, the dose is one drop in the affected eye(s) in the morning, in the PATIENT INFORMATION LEAFLET afternoon and in the evening.
5.
Your medication is available using the names Trusopt 2% Eye Drops Solution / Dorzolamide 2% Eye Drops Solution, but will be referred to as Trusopt throughout this leaflet.
Read all of this leaflet carefully before you start using this medicine.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
• If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What Trusopt is and what it is used for
2. Before you use Trusopt
3. How to use Trusopt
4. Possible side effects
5. How to store Trusopt
6. Further information
1. WHAT TRUSOPT IS AND WHAT IT IS USED FOR
Trusopt contains dorzolamide which belongs to a group of medicines called "carbonic anhydrase inhibitors".
This medicine is prescribed to lower raised pressure in the eye and to treat glaucoma. This medicine can be used alone or in addition to other medicines which lower the pressure in the eye (so-called beta-blockers).
2. BEFORE YOU USE TRUSOPT Do not use Trusopt
• if you are allergic (hypersensitive) to dorzolamide hydrochloride or any of the other ingredients of this medicine.
• if you have severe kidney impairment or problems, or a prior history of kidney stones.
Take special care with Trusopt
Tell your doctor about any medical problems you have now or have had in the past, including eye problems and eye surgeries, and about any allergies to any medications.
If you develop any eye irritation or any new eye problems such as redness of the eye or swelling of the eyelids, contact your doctor immediately.
If you suspect that this medicine is causing an allergic reaction (for example, skin rash, severe skin reaction or itching) stop its use and contact your doctor immediately.
Use in children.
Trusopt has been studied in infants and children less than 6 years of age who have raised pressure in the eye(s) or have been diagnosed with glaucoma. For more information, talk to your doctor.
Use in elderly.
In studies with Trusopt, the effects of Trusopt were similar in both elderly and younger patients.
Use in patients with liver impairment.
Tell your doctor about any liver problems you now have or have suffered from in the past.
Using other medicines
Tell your doctor about all drugs (including eye drops) that you are using or plan to use, including those obtained without a prescription, particularly another carbonic anhydrase inhibitor such as acetazolamide, or a sulfa drug.
Pregnancy and breast-feeding
Ask your doctor or pharmacist for advice before taking any medicine.
Use in pregnancy
You should not use this medicine during pregnancy. Tell your doctor if you are pregnant or intend to become pregnant.
Use in breast-feeding
If treatment with this medicine is required, breast-feeding is not recommended. Tell your doctor if you are breast-feeding or intend to breast-feed.
Driving and using machines
No studies on the effects on the ability to drive or use machines have been performed. There are side effects associated with this medicine, such as dizziness and blurred vision, which may affect your ability to drive and/or operate machinery. Do not drive or operate machinery until you feel well or your vision is clear.
Important information about some of the ingredients of Trusopt
Trusopt contains the preservative benzalkonium chloride. This preservative may be deposited in soft contact lenses and may possibly discolour the lenses. If you wear contact lenses, you should consult your doctor before using this medicine.
If your doctor has recommended you use this medicine with a beta-blocker eye drop to lower eye pressure, then the dose is one drop of Trusopt in the affected eye(s) in the morning and in the evening.
If you are using this medicine with another eye drop, the drops should be instilled at least 10 minutes apart.
Do not allow the tip of the container to touch the eye or areas around the eye. It may become contaminated with bacteria that can cause eye infections leading to serious damage of the eye, even loss of vision.
To avoid possible contamination, wash your hands before using this medicine and keep the tip of the container away from contact with any surface. If you think your medication may be contaminated, or if you develop an eye infection, contact your doctor immediately concerning continued use of this bottle.
Instructions for Use:
1. Before using the medication for the first time, be sure the Safety Strip on the front of the bottle is unbroken. A gap between the bottle and the cap is normal for an unopened bottle.
2. Tear off the Safety Strip to break the seal.
3. To open the bottle, unscrew the cap by turning as indicated by the arrows on the top of the cap. Do not pull the cap directly up and away from the bottle. Pulling the cap directly up will prevent your dispenser from operating properly.
4. Tilt your head back and pull your lower eyelid down slightly to form a pocket between your eyelid and your eye.
Invert the bottle, and press lightly with the thumb or index finger over the "Finger Push Area" (as shown) until a single drop is dispensed into the eye as directed by your doctor.
DO NOT TOUCH YOUR EYE OR EYELID WITH THE DROPPER TIP.
POM
6. If drop dispensing is difficult after opening for the first time, replace the cap on the bottle and
tighten (Do not overtighten) and then remove by turning the cap in the opposite directions as
indicated by the arrows on the top of the cap.
7. Repeat steps 4 & 5 with the other eye if instructed to do so by your doctor.
8. Replace the cap by turning until it is firmly touching the bottle. The arrow on the left side of the
cap must be aligned with the arrow on the left side of the bottle label for proper closure. Do not overtighten or you may damage the bottle and cap.
9. The dispenser tip is designed to provide a single drop; therefore, do NOT enlarge the hole of the dispenser tip.
10. After you have used all doses, there will be some medicine left in the bottle. You should not be concerned since an extra amount of medicine has been added and you will get the full amount of medicine that your doctor prescribed. Do not attempt to remove the excess medicine from the bottle.
If you use more Trusopt than you should
If you put too many drops in your eye or the contents of the container are swallowed, you should contact your doctor immediately.
If you forget to use Trusopt
It is important to take this medicine as prescribed by your doctor. If you miss a dose, take it as soon as possible. However, if it is almost time for the next dose, skip the missed dose and go back to your regular dosing schedule. Do not take a double dose to make up for the forgotten dose.
If you stop using Trusopt
If you want to stop using this medicine talk to your doctor first. If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Trusopt can cause side effects, although not everybody gets them.
If you develop allergic reactions including hives, swelling of the face, lips, tongue, and/or throat which may cause difficulty in breathing or swallowing, you should stop using this medicine and seek immediate medical advice.
The following side effects have been reported with Trusopt either during clinical trials or during postmarketing experience:
Very Common side effects: (more than 1 user in 10)
Burning and stinging of the eyes.
Common side effects: (1 to 10 users in 100)
Disease of the cornea with sore eye and blurred vision (superficial punctuate keratitis), discharge with itching of the eyes (conjunctivitis), irritation/inflammation of the eyelid, blurred vision, headache, nausea, bitter taste, and fatigue.
Uncommon side effects: (1 to 10 users in 1,000)
Inflammation of the iris.
Rare side effects: (1 to 10 users in 10,000)
Tingling or numbness of the hands or feet, temporary shortsightedness which may resolve when treatment is stopped, development of fluid under the retina (choroidal detachment, following filtration surgery), eye pain, eyelid crusting, low pressure in the eye, swelling of the cornea (with symptoms of visual disturbances), eye irritation including redness, kidney stones, dizziness, nose bleed, throat irritation, dry mouth, localized skin rash (contact dermatitis), severe skin reactions, allergic type reactions such as rash, hives, itching, in rare cases possible swelling of the lips, eyes and mouth, shortness of breath, and more rarely wheezing.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme. Website: www.mhra.gov.uk/yellowcard.
By reporting side effects, you can help provide more information on the safety of this medicine.
5. HOW TO STORE TRUSOPT
KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.
Do not use Trusopt after the expiry date which is stated on the carton and bottle. The expiry date refers to the last day of that month.
Do not store above 30°C. Protect from light.
Discard 28 days after first opening.
If the solution becomes discoloured or shows any other sign of deterioration, take it to your pharmacist who will advise you.
If your doctor tells you to stop using the solution, please take it back to your pharmacist for safe disposal. Only keep the solution if your doctor tells you to.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. FURTHER INFORMATION
What Trusopt contains
Trusopt is a sterile eye drop solution. Trusopt contains 2% dorzolamide, a sulphonamide-related compound, as the active ingredient.
In addition, Trusopt contains the following inactive ingredients: hydroxyethylcellulose, mannitol E421, sodium citrate, sodium hydroxide, and water for injection.
Benzalkonium chloride (0.075mg/ml) is added as a preservative.
What Trusopt looks like and contents of the pack
Trusopt is available in bottles containing 5ml of clear solution.
Manufacturer
Your eye drops are made by: Laboratories Merck Sharp & Dohme, Chibret, Route de Marsat, Riom, 63963 Clermont-Ferrand Cedex 9, France.
Procured from within the EU and repackaged by: Doncaster Pharmaceuticals Group Ltd., Kirk Sandall, Doncaster, DN3 1QR.
Product Licence holder: BR Lewis Pharmaceuticals Ltd., Kirk Sandall, Doncaster, DN3 1QR.
PL No: 08929/0158
Leaflet revision and issue date (Ref): 21.01.15
TRUSOPT® is a registered trademark of Merck Sharp & Dohme Corp.
How can I learn more about Trusopt, increased eye pressure or glaucoma?
This leaflet gives you the most important information about Trusopt. If you have any questions after you have read it, ask your doctor or pharmacist, who can give you more information about Trusopt and your eye condition.
Further information about glaucoma is available from:
International Glaucoma Association (IGA),
Woodcote House, 15 Highpoint Business Village, Henwood, Ashford, Kent, TN24 8DH
Tel: 01233 648170
Registered Charity number 274681.
Alternatively, if you or someone you know has problems with their vision, and you require further advice or information, please phone the Royal National Institute for the Blind (RNIB) Helpline on 0303 123 9999, Monday to Friday 8.45am to 6pm and Saturday 9am to 4pm, calls charged at local rate.
(The IGA and RNIB are independent UK charities and are not associated with BR Lewis Pharmaceuticals Group Ltd.)
Page 2 of 2